Literature DB >> 2120383

Immunohistochemical localization of pituitary gonadotrophins and gonadal steroids confirms the 'two-cell, two-gonadotrophin' hypothesis of steroidogenesis in the human ovary.

M Kobayashi1, R Nakano, A Ooshima.   

Abstract

Ovaries from 37 women with normal menstrual cycles were analysed for localization of pituitary gonadotrophins and gonadal steroids using an immunohistochemical method. In the follicular phase, FSH and oestradiol-17 beta localized in the granulosa layer, and LH, progesterone and testosterone localized in the internal thecal layer. In the luteal phase, gonadotrophins and steroids localized in luteal cells. Particularly in the early luteal phase, FSH and oestradiol-17 beta localized in large luteal cells, and LH, progesterone and testosterone localized in small luteal cells. The results of the present immunohistochemical analysis confirm the two-cell, two-gonadotrophin hypothesis of steroidogenesis in the human ovary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120383     DOI: 10.1677/joe.0.1260483

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

Review 1.  The human luteal paracrine system: current concepts.

Authors:  C Nappi; A R Gargiulo; C Di Carlo
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

2.  Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins.

Authors:  Sivanandane Sittadjody; Justin M Saul; Sunyoung Joo; James J Yoo; Anthony Atala; Emmanuel C Opara
Journal:  Biomaterials       Date:  2012-12-28       Impact factor: 12.479

3.  Expression of manganese superoxide dismutase mRNA in reproductive organs during the ovulatory process and the estrous cycle of the rat.

Authors:  T Nomura; J Sasaki; H Mori; E F Sato; S Watanabe; S Kanda; J Matsuura; H Watanabe; M Inoue
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

4.  Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.

Authors:  Rana F Shayya; Marcus A Rosencrantz; Sandy S Chuan; Heidi Cook-Andersen; William E Roudebush; H Irene Su; Shunichi Shimasaki; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

5.  Assessment of the luteal phase in stimulated and substituted cycles.

Authors:  H M Fatemi
Journal:  Facts Views Vis Obgyn       Date:  2009

6.  Reliability of follicle-stimulating hormone measurements in serum.

Authors:  Alan A Arslan; Anne Zeleniuch-Jacquotte; Annekatrin Lukanova; Sabina Rinaldi; Rudolf Kaaks; Paolo Toniolo
Journal:  Reprod Biol Endocrinol       Date:  2003-06-18       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.